# Giant Red Reishi (Ganoderma lucidum 'Giant Red')

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/giant-red-reishi
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-28
**Evidence Score:** 2 / 10
**Category:** Mushroom/Fungi
**Also Known As:** Ganoderma lucidum 'Giant Red', Giant Red Lingzhi, Large Red Reishi, Cultivar Red Reishi, Enhanced Red Ganoderma, Giant Red Lingzhi Mushroom

## Overview

Giant Red Reishi (Ganoderma lucidum 'Giant Red') is a cultivated variant of reishi mushroom selected for high yields of ganoderic acids and beta-glucan polysaccharides. These triterpenoid and polysaccharide compounds are hypothesized to modulate [immune function](/ingredients/condition/immune-support) and exhibit [antioxidant activity](/ingredients/condition/antioxidant), though no clinical trials have been conducted specifically on this variant.

## Health Benefits

• No clinical health benefits documented - search results focus exclusively on cultivation methods rather than therapeutic effects
• Cultivation studies report yields of bioactive compounds (ganoderic acids up to 582 mg/L, polysaccharides up to 4.8 g/L) but without clinical correlation
• No human trials, RCTs, or meta-analyses available in the research dossier
• Evidence quality: Absent - no clinical studies provided
• Traditional medicinal uses not documented in the available research

## Mechanism of Action

Ganoderic acids present in Ganoderma lucidum variants act as lanostane-type triterpenoids that inhibit 5-alpha reductase and HMG-CoA reductase, and may modulate NF-κB signaling pathways to influence [inflammatory](/ingredients/condition/inflammation) cytokine production. [Beta-glucan](/ingredients/condition/immune-support) polysaccharides bind to Dectin-1 and toll-like receptors (TLR2, TLR4) on innate immune cells, promoting macrophage and natural killer cell activation. These mechanisms are established for the broader Ganoderma lucidum species; no pathway data exists specifically for the Giant Red cultivar.

## Clinical Summary

No human clinical trials have been conducted specifically on the Giant Red cultivar of Ganoderma lucidum. Cultivation research documents this variant's capacity to produce ganoderic acids up to 582 mg/L and polysaccharides up to 4.8 g/L under optimized growth conditions, but these are yield metrics without therapeutic correlation. General Ganoderma lucidum research includes small-scale human trials (typically 30–130 participants) suggesting modest immune-modulating and fatigue-reducing effects, but these findings cannot be directly extrapolated to the Giant Red variant. Evidence quality for this specific cultivar is currently absent, placing any health claims in the realm of theoretical extrapolation from species-level data.

## Nutritional Profile

Giant Red Reishi (Ganoderma lucidum 'Giant Red') shares the core nutritional architecture of Ganoderma lucidum species, with composition data primarily derived from cultivated fruiting bodies and mycelium studies rather than this specific cultivar. Macronutrients (dry weight basis): protein 10–18% (containing all essential amino acids; glutamic acid, aspartic acid, and leucine predominate), carbohydrates 60–75% (predominantly structural polysaccharides and chitin), fat 1–3% (predominantly unsaturated fatty acids including oleic and linoleic acid), dietary fiber 50–60% of dry weight (largely indigestible [beta-glucan](/ingredients/condition/immune-support)s and chitin, limiting caloric density). Moisture content of fresh fruiting bodies is approximately 85–90%. Bioactive compounds specific to cultivation studies of this 'Giant Red' variant: ganoderic acids (triterpenes) reported up to 582 mg/L in liquid fermentation media — primary triterpenes include ganoderic acids A, B, C, D, G, and H; polysaccharides (notably beta-1,3/1,6-glucans and heteropolysaccharides) reported up to 4.8 g/L in cultivation studies. Minerals: potassium (1,000–2,000 mg/100g dry weight), phosphorus (800–1,500 mg/100g), magnesium (100–200 mg/100g), calcium (200–600 mg/100g), zinc (5–10 mg/100g), iron (10–30 mg/100g), selenium (trace, cultivation-substrate-dependent). Vitamins: ergosterol (provitamin D2 precursor, 0.1–0.5% dry weight, UV-conversion-dependent), B-vitamins present in modest amounts including niacin (3–5 mg/100g), riboflavin (0.2–0.5 mg/100g), pantothenic acid (1–2 mg/100g). Bioavailability notes: chitin cell walls significantly impair nutrient and bioactive compound absorption from whole dried mushroom; hot water or dual extraction (water + ethanol) substantially increases polysaccharide and triterpene bioavailability; beta-glucan absorption is estimated at 30–60% depending on molecular weight and processing; triterpene bioavailability from whole mushroom is poorly characterized but extraction concentrates improve it markedly. The 'Giant Red' designation likely reflects morphological traits (larger pileus, deeper red pigmentation from higher ganoderic acid surface concentration) rather than a categorically distinct nutritional profile from standard G. lucidum strains.

## Dosage & Preparation

No clinically studied dosage ranges are available for Giant Red Reishi in any form (extract, powder, or standardized preparations). The research contains no information on human dosing, standardization methods, or therapeutic protocols. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

General Ganoderma lucidum preparations are associated with occasional gastrointestinal upset, dry mouth, and dizziness, particularly with powdered whole-mushroom products taken at doses above 2 g/day. Reishi mushroom extracts may potentiate anticoagulant and antiplatelet drugs such as warfarin and aspirin due to inhibitory effects on platelet aggregation, and caution is warranted when combined with antihypertensive medications given observed [blood pressure](/ingredients/condition/heart-health)-lowering activity. Hepatotoxicity has been reported in rare cases, primarily with concentrated powdered forms rather than water-based extracts, and [liver function](/ingredients/condition/detox) monitoring is advisable during prolonged use. Safety data in pregnant or breastfeeding individuals is insufficient, and use is not recommended during pregnancy without medical supervision.

## Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses were found in the research for Giant Red Reishi or general G. lucidum. The available research focuses entirely on cultivation techniques and yields rather than clinical outcomes, with no PubMed PMIDs provided.

## Historical & Cultural Context

The research provides no information about historical or traditional medicinal uses of Giant Red Reishi. Available sources focus exclusively on modern artificial cultivation methods developed since the 20th century, including wood log, sawdust bag, and liquid fermentation techniques.

## Synergistic Combinations

No synergistic ingredients identified due to lack of pharmacological data

## Frequently Asked Questions

### What is Giant Red Reishi and how does it differ from regular reishi?

Giant Red Reishi is a selectively cultivated strain of Ganoderma lucidum bred to produce larger fruiting bodies and higher concentrations of bioactive compounds, with documented yields of ganoderic acids up to 582 mg/L compared to lower outputs in standard wild-type strains. While it shares the same core bioactive classes — triterpenoids and beta-glucan polysaccharides — as conventional reishi, no clinical research has confirmed whether these higher compound yields translate into superior therapeutic effects in humans.

### Does Giant Red Reishi have any proven health benefits?

Currently, no clinical trials have been published specifically investigating the Giant Red cultivar for any health outcome. Available research focuses entirely on cultivation optimization and compound yield measurements rather than therapeutic applications. Any attributed benefits are extrapolated from the broader Ganoderma lucidum species literature, which itself is characterized by small, often methodologically limited human trials.

### How much ganoderic acid does Giant Red Reishi contain?

Cultivation studies report that optimized Giant Red Reishi production can yield ganoderic acids at concentrations up to 582 mg/L in liquid fermentation systems, and polysaccharides up to 4.8 g/L. These figures represent production-environment outputs and may not directly reflect concentrations found in finished commercial supplements, which vary significantly by extraction method, solvent used, and standardization practices.

### Is Giant Red Reishi safe to take with blood thinners?

Ganoderma lucidum preparations, including variants like Giant Red Reishi, have demonstrated antiplatelet and anticoagulant activity in preclinical studies, including inhibition of ADP-induced platelet aggregation. This creates a meaningful interaction risk with anticoagulant drugs such as warfarin or direct oral anticoagulants (DOACs) and antiplatelet agents like clopidogrel, potentially increasing bleeding risk. Individuals on any blood-thinning medication should consult a physician before using any reishi supplement.

### What is the recommended dosage for Giant Red Reishi supplements?

No dosage has been clinically established specifically for the Giant Red cultivar. General Ganoderma lucidum dosing used in human research typically ranges from 1.5 g to 9 g per day of dried whole mushroom equivalent, or 1–1.5 g/day of a standardized extract. Because compound concentration in Giant Red preparations may differ from standard reishi products, consumers should follow manufacturer standardization data and start at lower doses to assess individual tolerance.

### What makes Giant Red Reishi different from other reishi cultivars in terms of bioactive compound production?

Giant Red Reishi cultivation studies demonstrate the potential for higher yields of ganoderic acids (up to 582 mg/L) and polysaccharides (up to 4.8 g/L) compared to standard reishi varieties, though these are laboratory measurements rather than clinical endpoints. The 'Giant Red' designation primarily reflects cultivation optimization for bioactive compound concentration rather than documented superior health outcomes. These yield differences are meaningful for supplement manufacturers but have not been validated in human clinical trials.

### Is Giant Red Reishi safe for pregnant women or nursing mothers?

There are no clinical safety studies specifically evaluating Giant Red Reishi use during pregnancy or lactation, so it cannot be recommended for these populations without consulting a healthcare provider. While traditional reishi has a long history of use in Asian medicine, the absence of human trials means safety cannot be confirmed for this cultivar variant. Pregnant and nursing women should seek professional medical guidance before adding any reishi supplement to their regimen.

### How does the extraction method affect the quality and potency of Giant Red Reishi supplements?

Extraction methods (hot water, alcohol, or dual extraction) significantly influence which bioactive compounds are concentrated in the final supplement, as ganoderic acids and polysaccharides have different solubility profiles. However, no comparative clinical studies have established which extraction approach produces the most therapeutically relevant form for human consumption. Manufacturers vary widely in their extraction protocols, making standardization and quality control critical factors in supplement selection.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*